Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.

Abstract

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of arthritis of autoimmune aetiology. Systemic-onset juvenile idiopathic arthritis (soJIA) presents with fever, transient erythematous rash, hepatomegaly, splenomegaly, lymphadenopathy, and serositis. SoJIA presents multiple complications, and the most severe is the macrophage activation syndrome (MAS); the timely treatment of MAS must be established early and aggressively to avoid a fatal outcome. Therapeutic plasma exchange has anecdotally been used in refractory cases. A 66-month-old male with a 1-year illness characterized by evening-predominant, intermittent fever, adenomegalies, urticarial-like rash, arthralgia, and arthritis. Biochemical analysis revealed anaemia, leukocytosis, neutrophilia, hypertriglyceridemia, hyperferritinemia, and hypofibrinogenemia; bone marrow aspirate showed hemophagocytosis. He was diagnosed with SoJIA complicated with MAS. He received multiple treatments with IV human gammaglobulin, cyclosporine, dexamethasone, and tocilizumab without improvement. Plasma replacement treatment was performed. Afterwards, he presented significant improvement. After 3-year-follow-up, he remains in good general condition. We present a refractory case of soJIA complicated with MAS successfully treated with plasma exchange.

• Authors: Eduardo Liquidano-Perez, Gibert Maza-Ramos, José Luis Salazar-Bailón, Marco Antonio Yamazaki-Nakashimada, Francisco Rivas-Larrauri
• Journal: Rheumatology international (Rheumatol Int) Vol. 43 Issue 1 Pg. 183-189 (01 2023) ISSN: 1437-160X [Electronic] Germany
• PMID: 36264324 (Publication Type: Journal Article, Review)
• Copyright: © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Topics

• Humans
• Male
• Child, Preschool
• Arthritis, Juvenile (complications, therapy, diagnosis)
• Macrophage Activation Syndrome (complications, therapy)
• Plasma Exchange (adverse effects)
• Lymphohistiocytosis, Hemophagocytic (complications)
• Exanthema